Roser Pujol

1.3k total citations
9 papers, 188 citations indexed

About

Roser Pujol is a scholar working on Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Roser Pujol has authored 9 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Genetics and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in Roser Pujol's work include DNA Repair Mechanisms (7 papers), CRISPR and Genetic Engineering (4 papers) and BRCA gene mutations in cancer (4 papers). Roser Pujol is often cited by papers focused on DNA Repair Mechanisms (7 papers), CRISPR and Genetic Engineering (4 papers) and BRCA gene mutations in cancer (4 papers). Roser Pujol collaborates with scholars based in Spain, Germany and France. Roser Pujol's co-authors include Jordi Surrallés, Massimo Bogliolo, Jean Soulier, Dominique Stoppa‐Lyonnet, Nadia Vasquez, Dominique Bluteau, Thierry Leblanc, James Lespinasse, Catherine Dubois d’Enghien and Detlev Schindler and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Scientific Reports.

In The Last Decade

Roser Pujol

9 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roser Pujol Spain 7 154 73 36 29 26 9 188
Ahlem Amouri Tunisia 9 169 1.1× 127 1.7× 51 1.4× 15 0.5× 35 1.3× 27 257
Nour Ewida Saudi Arabia 9 255 1.7× 138 1.9× 33 0.9× 28 1.0× 26 1.0× 9 328
Jacopo Azzollini Italy 13 208 1.4× 196 2.7× 47 1.3× 50 1.7× 21 0.8× 25 324
Masaki Yagi Japan 9 306 2.0× 78 1.1× 23 0.6× 32 1.1× 5 0.2× 12 341
Mara Colombo Italy 10 156 1.0× 118 1.6× 50 1.4× 36 1.2× 13 0.5× 15 250
Teresa Olbrich United States 8 243 1.6× 51 0.7× 14 0.4× 24 0.8× 40 1.5× 10 305
Emilie Abby Germany 6 264 1.7× 65 0.9× 71 2.0× 26 0.9× 41 1.6× 8 326
Emma V. Watson United States 7 85 0.6× 56 0.8× 46 1.3× 60 2.1× 10 0.4× 8 195
Wendy A. van Zelst-Stams Netherlands 5 87 0.6× 53 0.7× 58 1.6× 45 1.6× 15 0.6× 5 168
Leah L. Zagore United States 6 293 1.9× 39 0.5× 52 1.4× 8 0.3× 35 1.3× 10 341

Countries citing papers authored by Roser Pujol

Since Specialization
Citations

This map shows the geographic impact of Roser Pujol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roser Pujol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roser Pujol more than expected).

Fields of papers citing papers by Roser Pujol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roser Pujol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roser Pujol. The network helps show where Roser Pujol may publish in the future.

Co-authorship network of co-authors of Roser Pujol

This figure shows the co-authorship network connecting the top 25 collaborators of Roser Pujol. A scholar is included among the top collaborators of Roser Pujol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roser Pujol. Roser Pujol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Casado, José Antonio, Antonio Valeri, Rebeca Sánchez‐Domínguez, et al.. (2022). Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia. Journal of Clinical Investigation. 132(15). 4 indexed citations
2.
Castells‐Roca, Laia, Sara Gutiérrez‐Enríquez, Sandra Bonache, et al.. (2021). Clinical consequences of BRCA2 hypomorphism. npj Breast Cancer. 7(1). 117–117. 6 indexed citations
3.
Sánchez‐Domínguez, Rebeca, Sandra Rodríguez, Roser Pujol, et al.. (2020). TALEN mediated gene editing in a mouse model of Fanconi anemia. Scientific Reports. 10(1). 6997–6997. 5 indexed citations
4.
Keupp, Katharina, Stephanie Hampp, Monika Maringa, et al.. (2019). Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia‐like phenotype, and no chromosome fragility. Molecular Genetics & Genomic Medicine. 7(9). e863–e863. 20 indexed citations
5.
Krausz, Csilla, Antoni Riera‐Escamilla, Chiara Chianese, et al.. (2018). From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia. Genetics in Medicine. 21(1). 189–194. 29 indexed citations
6.
Bogliolo, Massimo, Dominique Bluteau, James Lespinasse, et al.. (2017). Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia. Genetics in Medicine. 20(4). 458–463. 54 indexed citations
7.
Pujol, Roser, Benjamín Rodríguez‐Santiago, Miriam Aza‐Carmona, et al.. (2017). Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia. Blood Advances. 1(5). 319–329. 17 indexed citations
8.
Osório, Ana, Massimo Bogliolo, María Victoria Fernández, et al.. (2013). Evaluation of Rare Variants in the New Fanconi Anemia GeneERCC4(FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles. Human Mutation. 34(12). 1615–1618. 26 indexed citations
9.
Trujillo‐Quintero, Juan Pablo, Leonardo Mina, Roser Pujol, et al.. (2012). On the role of FAN1 in Fanconi anemia. Blood. 120(1). 86–89. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026